Core Insights - Zinzino AB reported significant growth in revenue and profitability for the year 2025, leading to a proposed dividend increase of 50% to SEK 6 per share [1] Financial Performance - Q4 2025 revenue reached SEK 1,035.3 million, a 45% increase from SEK 713.5 million in Q4 2024, with local currency growth at 52% [1] - EBITDA for Q4 2025 rose to SEK 175.2 million, up from SEK 72.9 million, resulting in an EBITDA margin of 16.9%, compared to 10.2% in the previous year [1] - Full-year 2025 revenue totaled SEK 3,337.5 million, reflecting a 51% growth from SEK 2,207.8 million in 2024 [1] - Full-year EBITDA was SEK 443.4 million, up from SEK 250.7 million, with an EBITDA margin of 13.3%, compared to 11.4% in 2024 [1] Strategic Developments - Zinzino acquired 35% of Xion International Group to secure a sustainable supply of omega-3 for its main product, BalanceOil [1] - The company also acquired the assets of Sanki to enhance distribution capabilities in North and South America [1] - A new Gut Health Test was launched during the quarter [1] Cash Flow and Profitability - Cash flow from operating activities for Q4 2025 was SEK 271.5 million, compared to SEK 174.7 million in Q4 2024 [1] - Net profit for Q4 2025 was SEK 123.7 million, up from SEK 43.2 million, with net profit per share after tax at SEK 3.41, compared to SEK 1.25 in the previous year [1] - For the full year, cash flow from operating activities was SEK 541.8 million, up from SEK 303.1 million in 2024 [1] Dividend Proposal - The Board of Directors proposed a dividend of SEK 6.00 per share for the 2025 financial year, totaling SEK 217.9 million before dilution [1]

Core Insights - Zinzino has launched an innovative Gut Health Test that provides insights into gut-metabolic activity, influencing immunity and overall health [1][2][3] - The test is the first commercial product to measure gut bacteria production and the body's response, making preventative gut health routines more accessible [1][2] Company Overview - Zinzino is a Scandinavian health and wellness company focused on empowering individuals with tools for informed health decisions [4] - The company aims to contribute positively to global preventative health by providing insights into individual health at a cellular level [4] Product Details - The Gut Health Test requires a simple at-home finger prick to collect blood, eliminating the need for stool samples [1][7] - It measures gut function and the impact on the immune system, allowing individuals to make dietary and lifestyle adjustments based on results [2][3] - Test results can lead to personalized recommendations for improving gut health, such as stress management and increased fiber intake [3] Market Position - Zinzino positions itself as a leader in the gut health testing market, emphasizing the importance of gut health in overall well-being [3][4] - The test is available for purchase online and through selected distributors, indicating a strategic approach to market accessibility [2]